Do Gastric Signet Ring Cell Carcinomas and ECL‐Cell Neuroendocrine Tumours Have a Common Origin?
Peer reviewed, Journal article
Published version
![Thumbnail](/ntnu-xmlui/bitstream/handle/11250/2991269/Fossmark%2bR%2b2022%2bDo%2bgastric%2bsignet%2bring%2bcell%2bcarcinomas%2band%2bECL%2bcell%2bNETs%2bhave%2ba%2bcommon%2borigin.pdf.jpg?sequence=6&isAllowed=y)
View/ Open
Date
2022Metadata
Show full item recordCollections
- Institutt for klinisk og molekylær medisin [3578]
- Publikasjoner fra CRIStin - NTNU [38484]
- St. Olavs hospital [2558]
Original version
https://doi.org/10.3390/medicina58040470Abstract
Gastric cancer is a heterogenous group of tumours, and a better understanding of the carcinogenesis and cellular origin of the various sub-types could affect prevention and future treatment. Gastric neuroendocrine tumours (NETs) and adenocarcinomas that develop in the gastric corpus and fundus of patients with chronic atrophic gastritis have atrophic gastritis, hypoacidity, and hypergastrinemia as common risk factors and a shared cellular origin has been suggested. In particular, signet ring cell carcinomas have previously been suggested to be of neuroendocrine origin. We present a case of a combined gastric NET and signet ring cell carcinoma in a patient with hypergastrinemia due to autoimmune chronic atrophic gastritis. The occurrence of such a combined tumour strengthens the evidence that gastric NETs and signet ring cell carcinomas develop from a common origin.